Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead - 10x Genomics ( NASDAQ:TXG )

a week ago

10x Genomics Inc TXG stock is trading lower after the company, on Wednesday, released preliminary financial results for the third quarter of 2024, revealing a mixed performance.

Ticker	Sentiment	Impact
TXG	Neutral	49 %